Optogenetics is a big word that has become even bigger. The 2026 Nobel Prize for Physiology or Medicine just announced has been awarded to three scientists for developing a technique that allows light to be used to pinpoint which brain neurons cause which behavior disorders. The prize winners: Karl Deisseroth, Peter Hegemann, and Georg Nagel – were honored for their discoveries concerning light-gated ion channels and optogenetics. Peter Hegemann and Georg Nagel discovered a light-receptive protein in a single-celled alga known as channelrhodopsin. Karl Deisseroth transformed the protein into a light-controlled switch for nerve cells. Their discoveries lay the foundation of a new era in neuroscience and treatments for a variety of brain diseases.

Here’s a brief run-down on this magnificent discovery.

What is Optogenetics?

Optogenetics is a biological technique that combines genetics and optics to control and monitor the activity of individual cells, most commonly neurons, with millisecond-scale precision using light. The technique enables scientists to prove which parts of the brain – a hugely complex organ – controls what behavioral functions.

Needle in a Haystack

As we know, a neuron is a brain cell and there are at least 6 billion of them in your head. This means that finding neurons that cause specific behavioral disorders is like searching for a needle in a haystack.  

Neurons talk to each other through tiny electrical signals – everything you think, feel and do is neurons firing in signaling patterns. Before the said discovery, scientists mostly observe using brain scans but these show only correlation, not causation. We did have electrodes, tiny probes that zap brain tissue, but they hit every kind of cell, so there isn’t a way to zero on one type of neuron alone. The discoveries made by the three Nobel laureates made things much more precise.

Remarkably, what led to their discovery was an humble algae in a pond scum, and the light-sensitive protein that it contains. and they found a single-cell alga (Chlamydomonas) that swims toward light.

Eureka!

Chlamydomonas is a single-celled alga. In the early 2000s, Hagemann and Nagel found that a protein called channelrhodopsin in the alga allows it to swim toward light. The protein basically works like a door in the alga’s cell wall. Blue light opens the door, particles rush in and the cell is thus able to detect light signals.

In 2005, Deisseroth’s lab in Stanford put that protein into mouse brain cells so that blue light made certain cells fire, sort of like operating a remote control.

They flipped groups of neurons on and off while the mice moved around, and what they found was that when they flipped one group, the mouse froze in fear, but when they flipped another, it calmed down.

Using the same light-switching technique, they could even trigger or relieve depression-like symptoms and stop Parkinson-like shaking. Before this, scientists could only watch which brain areas lit up but now they could pinpoint which group of neurons in a huge, tangled bundle start or stop certain behaviors.

From the Lab to the Bedside

The range of illnesses that this discovery can benefit from optogenetics is wide. They include Schizophrenia, Parkinson’s Disease, Alzheimer’s Disease & Dementia, age-related macular degeneration and partial blindness. In September this year, the FDA started reviewing an eye injection for people going blind, which makes surviving eye cells sensitive to light. In the trial, partially blind patients could literally start seeing. Better drugs can now be developed for various kinds of brain disorders because drug makers know what to target instead of just guessing, which is huge because for most of history, brain drugs were only found by accident.

Who could have thought an ancient single-celled alga could literally open the door to a game-changing discovery?